Global Cancer Biological Therapy Market

Cancer Biological Therapy Market Size, Share, Growth Analysis, By Product(Cancer Growth Blockers, Monoclonal Antibodies, And Vaccines), By Distribution Channel(Hospital And Retail & Mail Order Pharmacies), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2207 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 61 |Figures: 75

Cancer Biological Therapy Market Insights

Cancer Biological Therapy Market size was valued at USD 77 billion in 2021 and is poised to grow from USD 79.50 billion in 2022 to USD 136.6 billion by 2030, at a CAGR of 7 % during the forecast period (2023-2030).

The rising frequency of cancer cases and the rising number of specialised cancer treatment facilities are predicted to drive a significant growth in the global market for cancer biological therapy.

In this industry, specialists are concentrating on employing nanotechnology to offer cutting-edge therapeutic solutions to cancer patients, opening up new paths for the development of treatments and individualized care.

The increasing focus on biological therapies and the incorporation of nanotechnology hold significant potential for revolutionizing cancer care and providing more individualized and effective treatments for patients around the world.

The global market for cancer biological therapy is positioned for extraordinary growth as research and technology developments continue to progress the sector, aiding in the continuous struggle against this terrible disease.

US Cancer Biological Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 77 billion

Largest Segment

Cancer Growth Blockers

Fastest Growth

Growth Rate

7% CAGR

Global Cancer Biological Therapy Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Cancer Biological Therapy Market Segmental Analysis

The global cancer biological therapy market is segmented on the basis of product, distribution channel, and region. By product, the market is studied across cancer growth blockers, monoclonal antibodies, and vaccines. By distribution channel, the market is studied across hospital and retail & mail order pharmacies. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Cancer Biological Therapy Market Analysis By Product

The biggest market sector, the cancer growth blockers, is crucial in preventing the unchecked proliferation of cancer cells. They provide a promising route for focused therapy, minimizing negative effects on healthy tissues and improving patient outcomes because of their specific mechanism of action. This market is a pillar in the fight against cancer due to the constantly growing pipeline of cancer growth blockers and their effectiveness in treating various cancer types.

The monoclonal antibody market, which is currently expanding at the quickest rate, signals the dawn of a new era of precision medicine. Monoclonal antibodies are a game-changer in the fight against cancer because of their potential for long-lasting effects and increased survival rates.

Cancer Biological Therapy Market Analysis By Distribution Channel

The largest component, hospital distribution channels, is crucial in enabling patients in various healthcare settings to get cancer biological therapies. Patients may easily receive these life-saving medicines thanks to the enormous worldwide hospital network, which makes this market sector a dominant force.

The retail and mail order pharmacy industry emerges as the distribution channel with the fastest rate of growth, revolutionizing patient access to cancer biological medicines. This practical distribution strategy not only increases accessibility for patients in isolated locations but also improves patient satisfaction and medication adherence. The approachable design of online platforms and the rising need for individualized healthcare solutions both contribute to the impressive expansion of this market.

Cancer Biological Therapy Market By Product, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Cancer Biological Therapy Market Regional Insights

Some locations stand out as potent driving factors in the fascinating world of the global market for cancer biological therapies, reshaping the landscape of cancer treatment and research. When it comes to advanced biological medicines and cancer care, North America is by far the dominant region. North America dominates the industry because of its excellent research institutions, sophisticated healthcare infrastructure, and strong emphasis on innovation. The region draws both top biotechnology businesses and healthcare investors because it has a substantial market share and acts as a center for clinical trials and drug development.

On the other hand, the Asia-Pacific area is revealed to be the region with the fastest growth rate, igniting interest and creating prospects for expansion in the worldwide market. Countries like China, India, and Japan are seeing a spike in the adoption of cancer biological treatments due to an increase in the prevalence of cancer cases and an increase in the desire for cutting-edge medicines. The market for cancer biological therapies is developing in the Asia-Pacific due to rising healthcare costs and encouraging government initiatives. In addition, the region's amazing economic trajectory is further fueled by the quick development of the healthcare infrastructure and the emergence of medical tourism. For instance, a top North American biotechnology company has created a ground-breaking monoclonal antibody therapy that targets certain cancer cells, improving patient outcomes and lengthening survival rates. This innovative therapy has revolutionized cancer treatment in the region, setting a benchmark for precision medicine. In the Asia-Pacific region, a prominent pharmaceutical company has established a state-of-the-art research facility focusing on cancer biological therapies. Their cutting-edge research and development efforts have led to the discovery of novel treatment options, catering to the specific needs of Asian patients and enhancing the region's capabilities in cancer care.

Cancer Biological Therapy Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cancer Biological Therapy Market Dynamics

Cancer Biological Therapy Market Drivers

Increasing Concerns to Monitor Cancer Cases

  • The increasing number of cancer cases worldwide is a significant driver fueling the growth of the global cancer biological therapy market during the forecast period. According to reports from the American Cancer Society, there has been a notable rise in Small Cell Lung Cancer (SCLC) cases, with a majority occurring in individuals between the ages of 60 and 80 years. The estimated global death rate from SCLC is approximately 30,000 per year. Additionally, data from the World Health Organization (WHO) reveals that lung cancer ranks as the second most prevalent cancer in both men and women, causing 1.59 million deaths in 2012. These alarming statistics contribute to the surge in demand for cancer biological therapies, propelling market growth to address the increasing burden of cancer on a global scale.

Cancer Biological Therapy Market Restraints

High Cost Of Treatment

  • The significant cost associated with cancer treatment methods poses a considerable challenge to the growth of the market. Many of these treatments come with high expenses, making it difficult for a considerable number of people, especially those in rural areas, to afford them. This financial burden acts as a major hindrance to market growth.

Request Free Customization of this report to help us to meet your business objectives.

Cancer Biological Therapy Market Competitive Landscape

The competitive landscape of the global cancer biological therapy market offers comprehensive details about each competitor. These details include company overview, company financials, revenue generated, market potential, research and development investments, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launches, product range, application dominance, and other relevant data points specifically related to the companies' involvement in the global cancer biological therapy market.

Cancer Biological Therapy Market Top Player’s Company Profiles

  • Amgen Inc. - United States
  • Merck & Co., Inc. - United States
  • Pfizer Inc. - United States
  • AstraZeneca - United Kingdom
  • Eli Lilly and Company - United States
  • GlaxoSmithKline plc - United Kingdom
  • Sanofi - France
  • Takeda Pharmaceutical Company Limited - Japan
  • Johnson & Johnson Services, Inc. - United States
  • AbbVie Inc. - United States
  • Gilead Sciences, Inc. - United States
  • Bayer AG - Germany
  • Celgene Corporation (acquired by Bristol-Myers Squibb) - United States
  • Astellas Pharma Inc. - Japan
  • Biogen Inc. - United States
  • Daiichi Sankyo Company, Limited - Japan
  • Seattle Genetics, Inc. - United States

Cancer Biological Therapy Market Recent Developments

  • In February 2022, The U.S. FDA's approval of CARVYKTI, also known as cilta cartagene autoleucel, was a key milestone for the Janssen Pharmaceutical Companies of Johnson & Johnson.
  • In May 2022, Bevacizumab, a cancer medication, was introduced in Canada under the trade name Abevmy by Biocon Biologics and Viatris, previously Mylan.

Cancer Biological Therapy Key Market Trends

  • The growing emphasis on personalized and targeted medicines is one major market trend in the global market for cancer biological therapies. The distinctive genetic and molecular properties of each tumor are now well understood because of developments in genomics and molecular biology. This has paved the way for the creation of biological cancer medicines that are specialized to target particular genetic abnormalities or biomarkers found in the cancer cells of the patient. Personalized cancer biological therapies have a number of benefits, including better patient outcomes, lower side effects, and increased therapeutic efficacy. These medicines efficiently restrict tumor growth and proliferation by carefully focusing on the molecular causes of the tumor, improving therapeutic outcomes.

Cancer Biological Therapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Deployment mode team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, The global cancer biological therapy market is anticipated to experience substantial growth over the forecast period. This growth can be attributed to the increasing number of cancer cases worldwide and the establishment of specialized cancer treatment facilities. Experts in the cancer biological therapy market are actively exploring the use of nanotechnology to provide advanced therapeutic solutions to patients.

Report Metric Details
Market size value in 2023 USD 77 billion
Market size value in 2031 USD 136.6 billion
Growth Rate 7%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Cancer Growth Blockers, Monoclonal Antibodies, And Vaccines
  • Distribution Channel
    • Hospital And Retail & Mail Order Pharmacies
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Amgen Inc. - United States
  • Merck & Co., Inc. - United States
  • Pfizer Inc. - United States
  • AstraZeneca - United Kingdom
  • Eli Lilly and Company - United States
  • GlaxoSmithKline plc - United Kingdom
  • Sanofi - France
  • Takeda Pharmaceutical Company Limited - Japan
  • Johnson & Johnson Services, Inc. - United States
  • AbbVie Inc. - United States
  • Gilead Sciences, Inc. - United States
  • Bayer AG - Germany
  • Celgene Corporation (acquired by Bristol-Myers Squibb) - United States
  • Astellas Pharma Inc. - Japan
  • Biogen Inc. - United States
  • Daiichi Sankyo Company, Limited - Japan
  • Seattle Genetics, Inc. - United States
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cancer Biological Therapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cancer Biological Therapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cancer Biological Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cancer Biological Therapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cancer Biological Therapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cancer Biological Therapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cancer Biological Therapy Market size was valued at USD 77 billion in 2021 and is poised to grow from USD 79.50 billion in 2022 to USD 136.6 billion by 2030, at a CAGR of 7 % during the forecast period (2023-2030).

The competitive landscape of the cancer biological therapy market offers comprehensive details about each competitor. These details include company overview, company financials, revenue generated, market potential, research and development investments, new market initiatives, presence, production sites and facilities, production capacities, company strengths and weaknesses, product launches, product range, application dominance, and other relevant data points specifically related to the companies' involvement in the cancer biological therapy market. 'F. Hoffmann-La Roche Ltd - Switzerland', 'Bristol-Myers Squibb Company - United States', 'Novartis AG - Switzerland', 'Amgen Inc. - United States', 'Merck & Co., Inc. - United States', 'Pfizer Inc. - United States', 'AstraZeneca - United Kingdom', 'Eli Lilly and Company - United States', 'GlaxoSmithKline plc - United Kingdom', 'Sanofi - France', 'Takeda Pharmaceutical Company Limited - Japan', 'Johnson & Johnson Services, Inc. - United States', 'AbbVie Inc. - United States', 'Gilead Sciences, Inc. - United States', 'Bayer AG - Germany', 'Celgene Corporation (acquired by Bristol-Myers Squibb) - United States', 'Astellas Pharma Inc. - Japan', 'Biogen Inc. - United States', 'Daiichi Sankyo Company, Limited - Japan', 'Seattle Genetics, Inc. - United States'

The increasing number of cancer cases worldwide is a significant driver fueling the growth of the cancer biological therapy market during the forecast period. According to reports from the American Cancer Society, there has been a notable rise in Small Cell Lung Cancer (SCLC) cases, with a majority occurring in individuals between the ages of 60 and 80 years. The estimated death rate from SCLC is approximately 30,000 per year. Additionally, data from the World Health Organization (WHO) reveals that lung cancer ranks as the second most prevalent cancer in both men and women, causing 1.59 million deaths in 2012. These alarming statistics contribute to the surge in demand for cancer biological therapies, propelling market growth to address the increasing burden of cancer on a scale.

The growing emphasis on personalized and targeted medicines is one major market trend in the market for cancer biological therapies. The distinctive genetic and molecular properties of each tumor are now well understood because of developments in genomics and molecular biology. This has paved the way for the creation of biological cancer medicines that are specialized to target particular genetic abnormalities or biomarkers found in the cancer cells of the patient. Personalized cancer biological therapies have a number of benefits, including better patient outcomes, lower side effects, and increased therapeutic efficacy. These medicines efficiently restrict tumor growth and proliferation by carefully focusing on the molecular causes of the tumor, improving therapeutic outcomes.

Some locations stand out as potent driving factors in the fascinating world of the market for cancer biological therapies, reshaping the landscape of cancer treatment and research. When it comes to advanced biological medicines and cancer care, North America is by far the dominant region. North America dominates the industry because of its excellent research institutions, sophisticated healthcare infrastructure, and strong emphasis on innovation. The region draws both top biotechnology businesses and healthcare investors because it has a substantial market share and acts as a center for clinical trials and drug development.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cancer Biological Therapy Market

Product ID: SQMIG35H2207

$5,300
BUY NOW GET FREE SAMPLE